Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.8.0.1
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Basic and diluted numerator:    
Net loss attributable to iBio, Inc. stockholders $ (3,826) $ (3,061)
Preferred stock dividends (66) 0
Net loss available to iBio, Inc. stockholders $ (3,892) $ (3,061)
Basic and diluted denominator:    
Weighted-average common shares outstanding 91,853 89,109
Per share amount $ (0.04) $ (0.03)